Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma
K Ishitsuka, K Tamura - The Lancet Oncology, 2014 - thelancet.com
Adult T-cell leukaemia-lymphoma (ATL) is a malignancy of peripheral T lymphocytes caused
by human T-lymphotropic virus type I (HTLV-1), and its prognosis is poor. There are an …
by human T-lymphotropic virus type I (HTLV-1), and its prognosis is poor. There are an …
Genetic variants of dectin-1 and their antifungal immunity impact in hematologic malignancies: a comprehensive systematic review
Background Fungal infections pose a significant threat to individuals with hematologic
malignancies due to compromised immune systems. Dectin-1, a pivotal pattern recognition …
malignancies due to compromised immune systems. Dectin-1, a pivotal pattern recognition …
Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers
Successful treatment of many patients with advanced cancer using antibodies against
programmed cell death 1 (PD-1; also known as PDCD1) and its ligand (PD-L1; also known …
programmed cell death 1 (PD-1; also known as PDCD1) and its ligand (PD-L1; also known …
Integrated molecular analysis of adult T cell leukemia/lymphoma
Adult T cell leukemia/lymphoma (ATL) is a peripheral T cell neoplasm of largely unknown
genetic basis, associated with human T cell leukemia virus type-1 (HTLV-1) infection. Here …
genetic basis, associated with human T cell leukemia virus type-1 (HTLV-1) infection. Here …
Revised adult T-cell leukemia-lymphoma international consensus meeting report
Purpose Adult T-cell leukemia-lymphoma (ATL) is a distinct mature T-cell malignancy
caused by chronic infection with human T-lymphotropic virus type 1 with diverse clinical …
caused by chronic infection with human T-lymphotropic virus type 1 with diverse clinical …
Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study
T Ishida, T Joh, N Uike, K Yamamoto… - Journal of Clinical …, 2012 - ascopubs.org
Purpose Adult T-cell leukemia-lymphoma (ATL) is usually resistant to conventional
chemotherapies, and there are few other treatment options. Because CC chemokine …
chemotherapies, and there are few other treatment options. Because CC chemokine …
Rapid progression of adult T-cell leukemia–lymphoma after PD-1 inhibitor therapy
Progression of T-Cell Leukemia with Nivolumab Three patients with chronic, smoldering,
and acute subtypes of adult T-cell leukemia–lymphoma had rapid disease progression and …
and acute subtypes of adult T-cell leukemia–lymphoma had rapid disease progression and …
Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-cc chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma …
M Ogura, T Ishida, K Hatake, M Taniwaki… - Journal of Clinical …, 2014 - ascopubs.org
Purpose CC chemokine receptor 4 (CCR4) is expressed by peripheral T-cell lymphomas
(PTCLs) and is associated with poor outcomes. Mogamulizumab (KW-0761) is a …
(PTCLs) and is associated with poor outcomes. Mogamulizumab (KW-0761) is a …
Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases
DU Gonçalves, FA Proietti, JGR Ribas… - Clinical microbiology …, 2010 - Am Soc Microbiol
Human T-cell leukemia virus type 1 (HTLV-1), the first human retrovirus to be discovered, is
present in diverse regions of the world, where its infection is usually neglected in health care …
present in diverse regions of the world, where its infection is usually neglected in health care …
An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma
K Izutsu, S Makita, K Nosaka, M Yoshimitsu… - Blood, 2023 - ashpublications.org
Adult T-cell leukemia/lymphoma (ATL) is an aggressive non-Hodgkin lymphoma with poor
prognosis and few treatment options for patients with relapsed, recurrent, or refractory …
prognosis and few treatment options for patients with relapsed, recurrent, or refractory …